Figure 3From: Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatmentCorrelation of differences in serum levels at baseline and 1 year of (a) metalloproteinase-3 (d_MMP-3) and C-reactive protein (d_CRP), (b) vasoendothelial growth factor (d_VEGF) and d_CRP, (c) bone-specific alkaline phosphatase (d_BALP) and d_CRP, and (d) d_MMP-3 and d_BALP.Back to article page